SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
Circulation · 20.08.2024 · 150 (8) · 622-641
DOI: 10.1161/circulationaha.123.066879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 20.08.2024. Verfasst von Anna Kovilakath und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human and Molecular Genetics (A.K., M.J., J.J.W., M.A.S.), Virginia Commonwealth University, Richmond. Hauptthemen laut MEDLINE: Cardiomyopathies, Electron Transport Complex I, Serine C-Palmitoyltransferase. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, BLRD VA, RRD VA.
Abstract (Originalsprache)
BACKGROUND: Dysregulated metabolism of bioactive sphingolipids, including ceramides and sphingosine-1-phosphate, has been implicated in cardiovascular disease, although the specific species, disease contexts, and cellular roles are not completely understood. Sphingolipids are produced by the serine palmitoyltransferase enzyme, canonically composed of 2 subunits, SPTLC1 (serine palmitoyltransferase long chain base subunit 1) and SPTLC2 (serine palmitoyltransferase long chain base subunit 2). Noncanonical sphingolipids are produced by a more recently described subunit, SPTLC3 (serine palmitoyltransferase long chain base subunit 3). METHODS: The noncanonical (d16) and canonical (d18) sphingolipidome profiles in cardiac tissues of patients with end-stage ischemic cardiomyopathy and in mice with ischemic cardiomyopathy were analyzed by targeted lipidomics. Regulation of SPTLC3 by HIF1α under ischemic conditions was determined with chromatin immunoprecipitation. Transcriptomics, lipidomics, metabolomics, echocardiography, mitochondrial electron transport chain, mitochondrial membrane fluidity, and mitochondrial membrane potential were assessed in the cSPTLC3 KO transgenic mice we generated. Furthermore, morphological and functional studies were performed on cSPTLC3 KO mice subjected to permanent nonreperfused myocardial infarction. RESULTS: Herein, we report that SPTLC3 is induced in both human and mouse models of ischemic cardiomyopathy and leads to production of atypical sphingolipids bearing 16-carbon sphingoid bases, resulting in broad changes in cell sphingolipid composition. This induction is in part attributable to transcriptional regulation by HIF1α under ischemic conditions. Furthermore, cardiomyocyte-specific depletion of SPTLC3 in mice attenuates oxidative stress, fibrosis, and hypertrophy in chronic ischemia, and mice demonstrate improved cardiac function and increased survival along with increased ketone and glucose substrate metabolism utilization. Depletion of SPTLC3 mechanistically alters the membrane environment and subunit composition of mitochondrial complex I of the electron transport chain, decreasing its activity. CONCLUSIONS: Our findings suggest a novel essential role for SPTLC3 in electron transport chain function and a contribution to ischemic injury by regulating complex I activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human and Molecular Genetics (A.K., M.J., J.J.W., M.A.S.), Virginia Commonwealth University, Richmond.
- Department of Internal Medicine, Division of Cardiology, Pauley Heart Center, Richmond, VA (A.G.M., J.T., Q.C., T.D., E.J.L., F.N.S.).
- C. Kenneth and Dianne Wright Center for Clinical and Translational Research (Y.A.V.), Virginia Commonwealth University, Richmond.
- Department of Biochemistry and Molecular Biology (Y.A.V., Y.Y., J.A., J.D., D.M., E.J.L., L.A.C.), Virginia Commonwealth University, Richmond.
- Department of Pediatrics, Division of Pediatric Cardiology (F.J.R.), Virginia Commonwealth University, Richmond.
- Bioinformatics Shared Resource, Massey Comprehensive Cancer Center (C.C., J.L.), Virginia Commonwealth University, Richmond.
ORCID-Profile: Anna Kovilakath, Adolfo G Mauro, Yolander A Valentine, Maryam Jamil, Christiane Carter, Qun Chen, Gisela Beutner, Jeremy Allegood, Xiaoxin X Wang, Komuraiah Myakala, Jolene J Windle, David Montefusco, Belinda Willard, Ali Javaheri, Tytus Bernas, Sushil K Mahata, Moshe Levi, Jinze Liu, George A Porter, Fadi N Salloum, L Ashley Cowart
Förderung
- NHLBI NIH HHS
- BLRD VA
- RRD VA
- NIDDK NIH HHS
- NIAAA NIH HHS
- NIA NIH HHS
- NIH HHS
- NCI NIH HHS
Zitieren
APA
Kovilakath, A., Mauro, A. G., Valentine, Y. A., Raucci, F. J., Jamil, M., Carter, C., Thompson, J., Chen, Q., Beutner, G., Yue, Y., Allegood, J., Wang, X. X., Dail, J., Devarakonda, T., Myakala, K., Windle, J. J., Subler, M. A., Montefusco, D., Willard, B., …, & Cowart, L. A. (2024). SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy. Circulation, 150(8), 622-641. https://doi.org/10.1161/circulationaha.123.066879
Vancouver
Kovilakath A, Mauro AG, Valentine YA, Raucci FJ, Jamil M, Carter C, et al. SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy. Circulation. 2024;150(8):622-641. doi:10.1161/circulationaha.123.066879
BibTeX
@article{Kovilakath2024,
author = {Kovilakath, Anna and Mauro, Adolfo G and Valentine, Yolander A and Raucci, Frank J and Jamil, Maryam and Carter, Christiane and Thompson, Jeremy and Chen, Qun and Beutner, Gisela and Yue, Yang and Allegood, Jeremy and Wang, Xiaoxin X and Dail, Jordan and Devarakonda, Teja and Myakala, Komuraiah and Windle, Jolene J and Subler, Mark A and Montefusco, David and Willard, Belinda and Javaheri, Ali and Bernas, Tytus and Mahata, Sushil K and Levi, Moshe and Liu, Jinze and Porter, George A and Lesnefsky, Edward J and Salloum, Fadi N and Cowart, L Ashley},
title = {SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy},
journal = {Circulation},
year = {2024},
volume = {150},
number = {8},
pages = {622--641},
doi = {10.1161/circulationaha.123.066879}
}
EUVIMED